Press "Enter" to skip to content

‘A Pinkalicious Phase’: What We Heard This Week

“We’re going to be in a ‘Pinkalicious phase’ for the next few months.” — Chris Martin, MD, MSc, of West Virginia University School of Public Health, quoting surprisingly apt advice from the popular children’s book series and applying it to potentially choosing one’s COVID vaccine.

“It is sloppy and lazy to lump cladribine and alemtuzumab together.” — Gavin Giovannoni, MBBCh, PhD, of Queen Mary University of London in England, discussing the issue of some multiple sclerosis drugs possibly attenuating antibody responses to COVID vaccination.

“I felt immense pain when he died because I knew how close I was [to suicide] when I was at his stage of education.” Christopher Veal, a fourth-year medical student at the University of Vermont in Burlington, reflecting on the suicide of a fellow student and his own brush with suicidal ideation.

“We are kind of surreptitiously — sometimes actually, overtly — feeding kids these messages like, ‘there’s never a wrong time to hate your body,'” — Christine Peat, PhD, of University of North Carolina in Chapel Hill, on the increase in eating disorder referrals among children and adolescents during the pandemic.

“The way you progress in science and medicine, is that you take observations from astute observers and pursue them with scientific rigor.” — Stanley Weiss, MD, of Rutgers New Jersey Medical School, discussing anecdotal evidence the COVID vaccine stems symptoms of “long COVID.”

“These are all barriers that will be hard to overcome.” — Lauren Davidson, of the University of Missouri-Kansas City School of Medicine, on how certain racial and ethnic minorities have been underrepresented in food allergy clinical trials.

Source: MedicalNewsToday.com